• SENSEX 78,009.25
    -70.71 (--0.09%)
  • BANKNIFTY 57,491.10
    -144.15 (--0.25%)
  • ICICI Pru Life
    511.95 706.50(%)
  • HDFC Bank
    729.65 1,020.35(%)
  • Apollo Hospitals
    8,925.00 9,326.80(%)
  • Wework India
    700.00 419.60(%)
  • LG Electronics
    1,736.35 1,736.40(%)
  • Gland Pharma
    3,039.00 3,039.00(%)
  • Bharti Airtel
    2,005.65 2,174.70(%)
  • Leap India
    143.10 143.10(%)
  • Blue Star
    1,497.00 1,450.00(%)
  • Cupid
    288.00 32.76(%)
  • Netweb Technol.
    4,995.00 2,037.65(%)
  • Honasa Consumer
    509.90 509.90(%)
  • Manorama Indust.
    1,867.00 1,867.00(%)
  • Vodafone Idea
    14.17 15.35(%)
  • Technocraft Ven.
    334.60 334.60(%)
  • Bharat Dynamics
    1,420.00 1,655.25(%)
  • Dixon Technolog.
    14,210.00 18,471.50(%)
  • Billionbrains
    194.60 112.02(%)
  • Infosys
    1,159.00 984.00(%)
  • Gujarat Fluoroch
    4,897.00 4,959.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Alkem Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 19299.0
  • ISIN : INE540L01014
5,368.00 -82 (-1.50%)
  • As on 15 Aug 2026 (EOD)

  • Today’s Low

    5,175.00

  • Today’s High

    5,448.00

  • Open

    5,432.00

  • Perv Close

    5,449.50

  • 52W Low

    5,075.00

  • 52W High

    5,933.50

Key Indicators

  • P/E(TTM)

    26.88

  • Mar.Cap (₹Cr.)

    64,182.49

  • Div & Yield %

    0.98

  • Book Value(₹)

    1,170.81

  • Debt-Equity Ratio

    -1.50

  • AGM Date

    14-Aug-2026

  • EPS

    200.88

  • P/E Ratio

    26.88

Financials Ratios

  • Debt-Equity Ratio

    0.15

  • Mar.Cap (₹Cr.)

    64,182.49

  • RONW (%)

    18.72

  • ROCE (%)

    18.29

Score Board

  • Equity (₹ in Cr.)

    23.91

  • BV (₹)

    1,170.80

  • Sales( ₹ in Cr.)

    9,690.18

  • NP (in Cr.)

    2,401.84

  • NP Var(%)

    6.0

  • Div%

    2650.0

  • CPS (₹)

    222.30

  • EPS (₹)

    200.90

  • Traded Value (₹ in Lakhs)

    64,553.14

  • 52 Week High

    5,933.50

  • 52 Week Low

    5,075.00

  • Price BSE

    5399.0

  • Price NSE

    5,368.00

  • Market Capital( in Cr.)

    64,553.14

  • P/C Ratio

    24.30

  • P/E Ratio

    26.90

  • Price Vs.BV

    200.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 9,690.18 8,831.13 7,972.25 9,054.55 8,829.81 7,219.68
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 9,690.18 8,831.13 7,972.25 9,054.55 8,829.81 7,219.68
Other Income 666.43 698.23 492.63 266.29 199.89 190.01
Stock Adjustments 45.67 -56.61 30.85 -257.73 360.90 301.29
Total Income 10,402.28 9,472.75 8,495.73 9,063.11 9,390.60 7,710.98
EXPENDITURE :            
Raw Materials 2,856.28 2,785.53 2,654.63 3,572.91 3,926.79 2,966.31
Power and Fuel Cost 126.89 128.35 123.85 126.32 129.53 100.12
Employee Cost 1,883.03 1,630.96 737.58 1,516.22 1,434.49 1,158.72
Other Manufacturing Expenses 489.49 509.57 439.03 361.12 399.80 280.51
Selling and Administration Expenses 1,904.99 1,673.04 1,617.16 1,739.71 1,438.80 1,007.42
Miscellaneous Expenses 208.16 -109.13 823.50 103.59 50.94 71.74
Employee Benefit Expenses 1,883.03 1,630.96 737.58 1,516.22 1,434.49 1,158.72
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 7,468.84 6,618.32 6,395.75 7,419.87 7,380.35 5,584.82
Operating Profit 2,933.44 2,854.43 2,099.98 1,643.24 2,010.25 2,126.16
Interest 57.29 76.11 80.07 86.40 37.90 42.93
Gross Profit 2,876.15 2,778.32 2,019.91 1,556.84 1,972.35 2,083.23
Depreciation 256.56 283.61 239.14 229.85 218.98 198.93
Profit Before Tax 2,619.59 2,494.71 1,780.77 1,326.99 1,753.37 1,884.30
Current Tax 432.00 350.13 32.82 227.52 303.82 331.83
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -94.50 -136.31 0.80 -35.00 -91.70 -132.61
Reported Net Profit 2,282.09 2,280.89 1,747.15 1,134.47 1,541.25 1,685.08
Extraordinary Items -119.75 5.56 -57.92 -10.24 1.82 16.49
Adjusted Net Profit 2,401.84 2,275.33 1,805.07 1,144.71 1,539.43 1,668.59
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 10,419.60 8,640.88 7,431.77 6,823.39 5,700.62 4,350.32
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 609.78 502.17 538.04 526.09 418.48 334.78
P & L Balance carried down 12,091.91 10,419.60 8,640.88 7,431.77 6,823.39 5,700.62
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 2,650.00 2,250.00 2,000.00 2,500.00 1,700.00 1,500.00
Dividend Per Share(Rs) 53.00 45.00 40.00 50.00 34.00 30.00
Earnings Per Share-Unit Curr 190.89 190.79 146.14 94.90 128.92 140.95
Earnings Per Share(Adj)-Unit Curr 190.89 190.79 146.14 94.90 128.92 140.95
Book Value 1,170.95 1,030.68 882.86 782.09 731.38 637.87
Book Value(Adj)-Unit Curr 1,170.95 1,030.68 882.86 782.09 731.38 637.87

Shareholding Pattern

  • Promoter Group

    49.70%

  • Public Share Holding

    50.30%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 59,424,889 49.70 59,424,889 21
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 59,424,889 49.70 59,424,889 21
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 52,942 0.04 52,942 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 12,454,390 10.42 12,454,390 548
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,938,303 4.13 4,938,303 19
Mutual Funds / UTI 19,973,392 16.71 19,973,392 29
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,095,333 1.75 2,095,333 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 39,514,360 33.05 39,514,360 611
2] Non Institution
Bodies Corporate 103,093 0.09 103,093 513
Clearing Members 15,008 0.01 15,008 23
Directors of their Relatives 1 0.00 1 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 75,296 0.06 75,296 2,044
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 40,967 0.03 40,967 1,901
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 18,997,660 15.89 18,997,660 17
Individuals holding nominal share capital up to Rs. 1 lakh 1,372,319 1.15 1,372,319 57,624
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,100 0.00 2,100 2
Others 557 0.00 557 2
Sub Total 20,625,751 17.25 20,625,751 62,190
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 119,565,000 100.00 119,565,000 62,822

Company Background

Alkem Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Alkem Laboratories Ltd
  • BSE Code : 19299.0
  • ISIN : INE540L01014

  • Incorporation Year

    1973

  • Registered Office

    Alkem House SenapatiBapat Marg
    Lower Parel, Mumbai,
    Maharashtra-400013

  • Telephone

    91-22-39829999

  • FAX

    91-22-24952955

  • Chairman

    Basudeo N Singh

  • Managing Director

    SANDEEP SINGH

  • Company Secretary

    Manish Narang

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Alkem Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Alkem Lab 5,399.00 10,219.08 9,663.91 28.29 18.77
Abbott India 27,076.90 7,217.19 6,929.05 35.63 43.78
Astrazeneca Phar 7,753.70 2,304.07 2,275.58 114.28 27.86
Glaxosmi. Pharma 2,689.10 3,932.76 3,790.20 42.96 58.17
Novartis India 1,586.70 398.23 356.27 40.07 16.64
Cipla 1,450.00 20,102.60 18,979.95 38.11 13.88
Bliss GVS Pharma 524.05 773.53 729.81 48.66 12.51
Amrutanjan Healt 494.75 469.50 451.82 26.50 21.89
Fermenta Biotec. 449.40 474.15 450.25 20.98 18.77
Guj. Themis Bio. 349.05 152.47 150.80 78.09 27.21
Ambalal Sarabhai 42.47 19.52 3.94 78.65 6.77